123 results on '"Manara E"'
Search Results
2. Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group
- Author
-
Manara, E, Basso, G, Zampini, M, Buldini, B, Tregnago, C, Rondelli, R, Masetti, R, Bisio, V, Frison, M, Polato, K, Cazzaniga, G, Menna, G, Fagioli, F, Merli, P, Biondi, A, Pession, A, Locatelli, F, and Pigazzi, M
- Published
- 2017
- Full Text
- View/download PDF
3. CREB engages C/EBPδ to initiate leukemogenesis
- Author
-
Tregnago, C, Manara, E, Zampini, M, Bisio, V, Borga, C, Bresolin, S, Aveic, S, Germano, G, Basso, G, and Pigazzi, M
- Published
- 2016
- Full Text
- View/download PDF
4. Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations
- Author
-
Manara, E, Bisio, V, Masetti, R, Beqiri, V, Rondelli, R, Menna, G, Micalizzi, C, Santoro, N, Locatelli, F, Basso, G, and Pigazzi, M
- Published
- 2014
- Full Text
- View/download PDF
5. ICER expression inhibits leukemia phenotype and controls tumor progression
- Author
-
Pigazzi, M, Manara, E, Baron, E, and Basso, G
- Published
- 2008
- Full Text
- View/download PDF
6. In vitro and clinical studies on the efficacy of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection
- Author
-
Poddesu, B., Cugia, G., Dhuli, K., Camilleri, G., Tuncel, G., Suer, H. Kaya, DÜNDAR, MUNİS, Sultanoglu, N., Sayan, M., Ergoren, M. C., Beccari, T., Ceccarini, M. R., Gunsel, I. S., Dautaj, A., Sanlidag, T., Connelly, S. T., Bertelli, M., Paolacci, S., De Forni, D., Tartaglia, G. M., and Manara, E.
- Subjects
viruses ,virus diseases ,lipids (amino acids, peptides, and proteins) - Abstract
OBJECTIVE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the current pandemic of coronavirus disease 2019 (COVID-19). This virus attacks cells of the airway epithelium by binding transmembrane angiotensin-converting enzyme 2 (ACE2). Hydroxytyrosol has anti-viral properties. Alpha-cyclodextrin can deplete sphingolipids and phospholipids from cell membranes. The aim of the present experimental study was to evaluate the efficacy of alpha-cyclodextrin and hydroxytyrosol in improving defenses against SARS-CoV-2 infection in in vitro cell models and humans.
- Published
- 2021
7. Identification of unsolved rare genetic cases of North Cyprus
- Author
-
Mahmut Cerkez Ergoren, Manara, E., Paolacci, S., Tuncel, G., Temel, S. G., Mocan, G., Dundar, M., and Bertelli, M.
- Published
- 2020
8. Vascular Involvement in Diabetic Subjects with Ischemic Foot Ulcer: A New Morphologic Categorization of Disease Severity
- Author
-
Graziani, L., Silvestro, A., Bertone, V., Manara, E., Andreini, R., Sigala, A., Mingardi, R., and De Giglio, R.
- Published
- 2007
- Full Text
- View/download PDF
9. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study
- Author
-
Garancini, M. P., Calori, G., Ruotolo, G., Manara, E., Izzo, A., Ebbli, E., Bozzetti, A. M., Boari, L., Lazzari, P., and Gallus, G.
- Published
- 1995
- Full Text
- View/download PDF
10. Naturally-occurring and cultured bacteriophages in human therapy.
- Author
-
KIANI, A. K., ANPILOGOV, K., DHULI, K., PAOLACCI, S., BENEDETTI, S., MANARA, E., GUERRI, G., DAUTAJ, A., BECCARI, T., DUNDAR, M., and BERTELLI, M.
- Abstract
OBJECTIVE: The aim of the study was to show the importance of developing techniques that could exploit the potential of bacteriophages as therapeutics or food supplements. MATERIALS AND METHODS: PubMed database was searched using the following combination of keywords: (bacteriophage) AND (human therapy); (natural bacteriophage) AND (application). RESULTS: The increasing antibiotic resistance of many bacterial strains is making standard antibiotic treatments less effective. Phage therapy provides a non-antibiotic alternative with greater specificity and without harmful effects on the human microbiota. Phages target their specific bacteria, replicate, and then, destroy the host pathogen. Bacteriophages may be administered by several routes, including topical, oral and intravenous. They not only destroy the host pathogen but, in some cases, increase the sensitivity of host bacteria to antibiotics. Various studies have shown that combining phage therapy and antibiotic treatment can be effective against bacterial infections. Clinical trials of phage therapy have shown promising results for various human diseases and conditions. With advances in genetic engineering and molecular techniques, bacteriophages will be able to target a wide range of bacteria. CONCLUSIONS: In the future, phage therapy promises to become an effective therapeutic option for bacterial infections. Since many potentially beneficial bacteriophages can be found in food, supplements containing bacteriophages could be designed to remodel gut microbiota and eliminate pathogenic bacteria. Remodeling of gut microbiota could correct gut dysbiosis. The order of phages known to have these promising activities is Caudovirales, especially the families Siphoviridae and Myoviridae. [ABSTRACT FROM AUTHOR]
- Published
- 2021
11. In vitro and clinical studies on the efficacy of α-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection.
- Author
-
PAOLACCI, S., ERGOREN, M. C., DE FORNI, D., MANARA, E., PODDESU, B., CUGIA, G., DHULI, K., CAMILLERI, G., TUNCEL, G., SUER, H. KAYA, SULTANOGLU, N., SAYAN, M., DUNDAR, M., BECCARI, T., CECCARINI, M. R., GUNSEL, I. S., DAUTAJ, A., SANLIDAG, T., CONNELLY, S. T., and TARTAGLIA, G. M.
- Abstract
OBJECTIVE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the current pandemic of coronavirus disease 2019 (COVID-19). This virus attacks cells of the airway epithelium by binding transmembrane angiotensin- converting enzyme 2 (ACE2). Hydroxytyrosol has anti-viral properties. Alpha-cyclodextrin can deplete sphingolipids and phospholipids from cell membranes. The aim of the present experimental study was to evaluate the efficacy of α-cyclodextrin and hydroxytyrosol in improving defenses against SARS-CoV-2 infection in in vitro cell models and humans. PATIENTS AND METHODS: For in vitro experiments on Vero E6 cells, RNA for RT-qPCR analysis was extracted from Caco2 and human fibroblast cell lines. For study in humans, the treatment group consisted of 149 healthy volunteers in Northern Cyprus, considered at higher risk of SARS-CoV-2 infection than the general population. The volunteers used nasal spray containing α-cyclodextrin and hydroxytyrosol for 4 weeks. The control group consisted of 76 healthy volunteers who did not use the spray. RESULTS: RT-qPCR experiments on targeted genes involved in endocytosis showed a reduction in gene expression, whereas cytotoxicity and cytoprotective tests showed that the compounds exerted a protective effect against SARS-CoV-2 infection at non-cytotoxic concentrations. None of the volunteers became positive to SARS-CoV-2 RT-qPCR assay during the 30 days of treatment. CONCLUSIONS: Treatment with α-cyclodextrin and hydroxytyrosol nasal spray improved defenses against SARS-CoV-2 infection and reduced synthesis of viral particles. [ABSTRACT FROM AUTHOR]
- Published
- 2021
12. Study of the effects of Lemna minor extracts on human immune cell populations.
- Author
-
CARDOSO, C. CATELANI, MIRALDI, E., CECCARINI, M. R., NAUREEN, Z., BAINI, G., MANARA, E., ANPILOGOV, K., CAMILLERI, G., DHULI, K., PAOLACCI, S., RIA, F., DI SANTE, G., CAMPONESCHI, C., TREDICINE, M., ZANLARI, A., CHIURAZZI, P., BECCARI, T., and BERTELLI, M.
- Abstract
OBJECTIVE: Lemna minor is a plant with a huge repertoire of secondary metabolites. The literature indicates that extracts of Lemna minor have antioxidant, antiradical, immunomodulatory and anti-inflammatory properties. The objective of the present study was to find a suitable technique to extract active compounds from this plant and verify whether these extracts have immunomodulatory activity. MATERIALS AND METHODS: We grew L. minor on a standard medium with Gamborg B5 and vitamins. We extracted compounds from the plant by maceration and decoction. The phytochemical profile of the extracts was characterized by chromatography, spectrophotometry, and spectroscopy. The extracts were tested on cultures of mononuclear cells from four human subjects. These cells were pulsed with carboxyfluorescein succinimidyl ester, grown in triplicate in standard culture medium without (control) and with increasing concentrations of Lemna extracts. Flow cytometry was used to evaluate cell death and proliferation of the total mononuclear cell population and of CD4+, CD8+, B cell and monocyte populations. RESULTS: The Lemna extracts were not cytotoxic and did not cause cell necrosis or apoptosis in immune cells. At low concentrations, they induced very limited proliferation of CD4+ cells within 48 hours. At high concentrations, they induced proliferation of CD8+ cells and B lymphocytes within 48 hours. CONCLUSIONS: Unfortunately, we failed to confirm any immunomodulatory activity of Lemna extracts. Growth and death rates of human immune cells were not significantly affected by adding Lemna extracts to the culture medium. [ABSTRACT FROM AUTHOR]
- Published
- 2021
13. Steroid-converting enzymes in human adipose tissues and fat deposition with a focus on AKR1C enzymes.
- Author
-
KIANI, A. K., MOR, M., BERNINI, A., FULCHERI, E., MICHELINI, S., HERBST, K. L., BUFFELLI, F., BELGRADO, J.-P., KAFTALLI, J., STUPPIA, L., DAUTAJ, A., DHULI, K., GUDA, T., MANARA, E., MALTESE, P. E., CHIURAZZI, P., PAOLACCI, S., CECCARINI, M. R., BECCARI, T., and BERTELLI, M.
- Abstract
Adipocytes express various enzymes, such as aldo-keto reductases (AKR1C), 11β-hydroxysteroid dehydrogenase (11β-HSD), aromatase, 5α-reductases, 3β-HSD, and 17β-HSDs involved in steroid hormone metabolism in adipose tissues. Increased activity of AKR1C enzymes and their expression in mature adipocytes might indicate the association of these enzymes with subcutaneous adipose tissue deposition. The inactivation of androgens by AKR1C enzymes increases adipogenesis and fat mass, particularly subcutaneous fat. AKR1C also causes reduction of estrone, a weak estrogen, to produce 17β-estradiol, a potent estrogen and, in addition, it plays a role in progesterone metabolism. Functional impairments of adipose tissue and imbalance of steroid biosynthesis could lead to metabolic disturbances. In this review, we will focus on the enzymes involved in steroid metabolism and fat tissue deposition. [ABSTRACT FROM AUTHOR]
- Published
- 2021
14. Genetics of fat deposition.
- Author
-
CAMILLERI, G., KIANI, A. K., HERBST, K. L., KAFTALLI, J., BERNINI, A., DHULI, K., MANARA, E., BONETTI, G., STUPPIA, L., PAOLACCI, S., DAUTAJ, A., and BERTELLI, M.
- Abstract
Adipose tissue distribution usually varies among men and women. In men, adipose tissue is known to accumulate in the abdominal region surrounding the visceral organs (android fat distribution) whereas, in women, the accumulation of adipose tissue generally occurs in the gluteal-femoral regions (gynoid fat distribution). In some cases, however, android distribution can be found in women and gynoid distribution can be found in men. The regulation of adipose tissue accumulation involves interaction of a variety of genetic and environmental factors. This review examines genetic factors that cause differential distribution of adipose tissue in different depots of the body, between men and women and between different ethnicities. Genome-wide association studies can be used to identify genetic associations with the distribution and accumulation of adipose tissue. Insight into adipose tissue accumulation and distribution mechanisms could lead to development of personalized interventions for people who develop increased fat mass. [ABSTRACT FROM AUTHOR]
- Published
- 2021
15. Pheromone receptors and their putative ligands: possible role in humans.
- Author
-
PRECONE, V., PAOLACCI, S., BECCARI, T., RAGIONE, L. DALLA, STUPPIA, L., BAGLIVO, M., GUERRI, G., MANARA, E., TONINI, G., HERBST, K. L., UNFER, V., and BERTELLI, M.
- Abstract
Pheromones are ectohormones that play an important role in communication and behavior. Pheromones and pheromone receptor genes are important in mice and other mammals that rely heavily on pheromone cues to survive. Although there is controversy about whether pheromones and pheromone receptor genes have the same importance or are even active in humans, there are some hints that they might have roles in sociosexual behavior and mental disorders. The aim of this qualitative review was to provide an overview of the state of the art regarding pheromones and pheromone receptors in humans and their possible implications in human physiology and pathology. An electronic search was conducted in MEDLINE, PubMed and Scopus databases for articles published in English up to December 2018. The search concerned a possible role of pheromones and pheromone receptors in humans with implications for sociosexual behavior, mental disorders, the menstrual cycle and nutrition. Pheromone communication in humans has not been definitively demonstrated. However, the potential ability of putative pheromones to activate the hypothalamus, which controls the release of many hormones, suggests they could have a role in systemic functions in humans. Future confirmation of the effects of pheromones and pheromone receptors in humans could be useful in the prevention and treatment of various human disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2020
16. Putative role of Brugada syndrome genes in familial atrial fibrillation.
- Author
-
MALTESE, P. E., ALDANOVA, E., KRIUCHKOVA, N., AVERIANOV, A., MANARA, E., PAOLACCI, S., BRUSON, A., MIOTTO, R., SARTORI, M., GUERRI, G., ZUNTINI, M., MARCEDDU, G., TEZZELE, S., TADTAEVA, K., CHERNOVA, A., AKSYUTINA, N., NIKULINA, S., NODARI, S., and BERTELLI, M.
- Abstract
OBJECTIVE: Familial atrial fibrillation (FAF), a not uncommon arrhythmia of the atrium, is characterized by heritability, early onset and absence of other heart defects. The molecular and genetic basis is still not completely clear and genetic diagnosis cannot be achieved in about 90% of patients. In this study, we present the results of genetic screening by next generation sequencing in affected Russian families. PATIENTS AND METHODS: Sixty subjects (18 probands and 42 relatives) with a clinical diagnosis of FAF were enrolled in the study. Since AF frequently associates with other cardiomyopathies, we included all genes that were known to be associated with these disorders at the time of our study. All probands were therefore systematically screened for 47 genes selected from the literature. RESULTS: Our study revealed that seven variants co-segregated with the clinical phenotype in seven families. Interestingly, four out of six genes and three out of seven variants have already been associated with Brugada syndrome in the literature. CONCLUSIONS: To our knowledge, this is the first report of association of the CACNA1C, CTNNA3, PKP2, ANK2 and SCN10A genes with FAF; it is also the first study in Russian families. [ABSTRACT FROM AUTHOR]
- Published
- 2019
17. PipeMAGI: an integrated and validated workflow for analysis of NGS data for clinical diagnostics.
- Author
-
MARCEDDU, G., DALLAVILLA, T., GUERRI, G., MANARA, E., CHIURAZZI, P., and BERTELLI, M.
- Abstract
OBJECTIVE: We describe how to set up a custom workflow for the analysis of next generation sequencing (NGS) data suitable for the diagnosis of genetic disorders and that meets the strictest standards of quality and accuracy. Our method goes from DNA extraction to data analysis with a computational in-house pipeline. The system was extensively validated using three publicly available Coriell samples, estimating accuracy, sensitivity and specificity. Multiple runs were also made to assess repeatability and reproducibility. MATERIALS AND METHODS: Three different Coriell samples were analyzed in a single run to perform coverage, sensitivity, specificity, accuracy, reproducibility and repeatability analysis. The three samples were analyzed with a custom-made oligonucleotide probe library using Nextera Rapid Capture enrichment technique and subsequently quantified using the Qubit method. Sample quality was verified using a 4200 TapeStation and sequenced on a MiSeq personal sequencer. Analysis of NGS data was then performed with a custom pipeline. RESULTS: The workflow enabled an accurate and precise analysis of NGS data that meets all the requirements of quality and accuracy required by international standards such as ISO15189 and the Association of Molecular Pathology. CONCLUSIONS: The proposed analysis/validation workflow has high assay accuracy, precision and robustness and can, therefore, be used for clinical diagnostic applications. [ABSTRACT FROM AUTHOR]
- Published
- 2019
18. Application of high-throughput DNA sequencing to score population-specific variants for rare disorders
- Author
-
Ergoren, M.C., Manara, E., Paolacci, S., Temel, S.G., Mocan, G., Dundar, M., and Bertelli, M.
- Published
- 2019
- Full Text
- View/download PDF
19. Next generation sequencing analysis of patients with Mendelian obesity
- Author
-
Paolacci, S., Maltese, P.E., Manara, E., Iarossi, G., Ziccardi, L., Colombo, L., Falsini, B., and Bertelli, M.
- Published
- 2019
- Full Text
- View/download PDF
20. Target and whole exome sequencing in families with lymphedema and lipedema
- Author
-
Maltese, P.E., Manara, E., Paolacci, S., Marceddu, G., Michelini, S., and Bertelli, M.
- Published
- 2019
- Full Text
- View/download PDF
21. Quality assurance of genetic laboratories and the EBTNA practice certification
- Author
-
Manara, E., Precone, V., Dundar, M., Beccari, T., Cecchin, S., Marceddu, G., and Bertelli, M.
- Published
- 2019
- Full Text
- View/download PDF
22. PIPE-MAGI, Bioinformatic system for the analysis of NGS data
- Author
-
Bertelli, M., Marceddu, G., Dallavilla, T., Guerri, G., Maltese, P.E., Manara, E., and Paolacci, S.
- Published
- 2019
- Full Text
- View/download PDF
23. Taste, olfactory and texture related genes and food choices: implications on health status.
- Author
-
PRECONE, V., BECCARI, T., STUPPIA, L., BAGLIVO, M., PAOLACCI, S., MANARA, E., MIGGIANO, G. A. D., FALSINI, B., TRIFIRÒ, A., ZANLARI, A., HERBST, K. L., UNFER, V., and BERTELLI, M.
- Abstract
OBJECTIVE: The food choices are due to a mixture of sensory signals including gustatory, olfactory, and texture sensations. The aim of this quality review was to update data about studies concerning genetics of taste, olfactory and texture receptors and their influence on the health status in humans. MATERIALS AND METHODS: An electronic search was conducted in MEDLINE, Pubmed database and Scopus, for articles published in English until December 2018. Two independent researches selected the studies and extracted the data. RESULTS: T he r eview c onfirms t he i mportance of inter-individual variations in taste, olfactory and texture related genes on food choices and their implications in the susceptibility to nutrition-related conditions such as obesity, dental caries, diabetes, cardiovascular disease, hypertension, hyperlipidemia and cancer. CONCLUSIONS: The knowledge of variants in taste, olfactory and texture related genes can contribute to the prevention of diseases related to unhealthy nutrition. Further studies would be useful to identify other variants in the genes involved in these systems. [ABSTRACT FROM AUTHOR]
- Published
- 2019
24. The Biennial report: The collaboration between MAGI Research, Diagnosis and Treatment Center of Genetic and Rare Diseases and Near East University DESAM Institute
- Author
-
Ergoren Mahmut Cerkez, Manara Elena, Paolacci Stefano, Cobanogullari Havva, Tuncel Gulten, Betmezoglu Meryem, Bertelli Matteo, and Sanlidag Tamer
- Subjects
rare-disease ,genomics ,high-throughput dna sequencing ,variants ,genetic disorders ,Biotechnology ,TP248.13-248.65 - Abstract
Scientific collaboration is more common now than it was before. In many areas of biomedical science, collaborations between researchers with different scientific backgrounds and perspectives have enabled researchers to address complicated questions and solve complex problems.
- Published
- 2020
- Full Text
- View/download PDF
25. Quality assurance of genetic laboratories and the EBTNA practice certification, a simple standardization assurance system for a laboratory network
- Author
-
Precone Vincenza, Dundar Munis, Beccari Tommaso, Turanli Eda Tahir, Cecchin Stefano, Marceddu Giuseppe, Manara Elena, and Bertelli Matteo
- Subjects
quality assurance ,iso ,ebtna quality system ,laboratory network ,genetic tests ,Biotechnology ,TP248.13-248.65 - Abstract
Analytical laboratory results greatly influence medical diagnosis, about 70% of medical decisions are based on laboratory results. Quality assurance and quality control are designed to detect and correct errors in a laboratory’s analytical process to ensure both the reliability and accuracy of test results. Unreliable performance can result in misdiagnosis and delayed treatment. Furthermore, improved quality guarantees increased productivity at a lower cost. Quality assurance programmes include internal quality control, external quality assessment, proficiency surveillance and standardization. It is necessary to try to ensure compliance with the requirements of the standards at all levels of the process. The sources of these standards are the International Standards Organization (ISO), national standards bodies, guidelines from professional organisations, accreditation bodies and governmental regulations. Laboratory networks increase the performance of laboratories in support of diagnostic screening programme. It is essential that genetic laboratories of a network have procedures underpinned by a robust quality assurance system to minimize errors and to reassure the clinicians and the patients that international standards are being met. This article provides an overview of the bases of quality assurance and its importance in genetic tests and it reports the EBTNA quality assurance system which is a clear and simple system available for access to adequate standardization of a genetic laboratory’s network.
- Published
- 2018
- Full Text
- View/download PDF
26. Microstructural variations in Cu/Nb and Al/Nb nanometallic multilayers.
- Author
-
Polyakov, M. N., Courtois-Manara, E., Wang, D., Chakravadhanula, K., Kübel, C., and Hodge, A. M.
- Subjects
- *
MULTILAYERS , *TRANSMISSION electron microscopy , *CRYSTALLOGRAPHY , *NANOSILICON , *CRYSTAL structure - Abstract
Miscible (Al/Nb) and immiscible (Cu/Nb) nanometallic multilayer systems were characterized by means of transmission electron microscopy techniques, primarily by automated crystallographic orientation mapping, which allows for the resolution of crystal structures and orientations at the nanoscale. By using this technique, distinctive Nb orientations in relation to the crystallographic state of the Al and Cu layer structures can be observed. Specifically, the Al and Cu layers were found to consist of amorphous, semi-amorphous, and crystalline regions, which affect the overall multilayer microstructure. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
27. Reply to the Letter "The development of Brugada syndrome phenotype is multifactorial, combining genetic and environmental factors".
- Author
-
Maltese, P. E., Aldanova, E., Kriuchkova, N., Averianov, A., Manara, E., Paolacci, S., Bruson, A., Miotto, R., Sartori, M., Guerri, G., Zuntini, M., Marceddu, G., Tezzele, S., Tadtaeva, K., Chernova, A., Aksyutina, N., Nikulina, S., Nodari, S., and Bertelli, M.
- Published
- 2020
28. What is Magi?
- Author
-
Manara Elena, Abeshi Andi, and Bertelli Matteo
- Subjects
magi ,genetics ,rare diseases ,Biotechnology ,TP248.13-248.65 - Abstract
MAGI is concerned with research and diagnosis of rare genetic diseases. It has been operating since 2006 in Italy and abroad. Today it has three centers in Italy, including a medical genetics laboratory specialized in next generation sequencing in Bolzano, a medical genetics laboratory specialized in MLPA in Rovereto (Trento) and a genetic diseases information center at San Felice del Benaco (Brescia). MAGI has also invested outside Italy, setting up non-profit genetics laboratories in countries such as Albania, Russia and in the near future, Kazakhstan.
- Published
- 2017
- Full Text
- View/download PDF
29. MAGI Balkans, a laboratory for the diagnosis of rare genetic diseases
- Author
-
Manara Elena, Maltese Paolo E., Guerri Giulia, Marceddu Giuseppe, Capodicasa Natale, Abeshi Andi, and Bertelli Matteo
- Subjects
craniosynostosis ,familial adenomatous polyposis ,frontotemporal dementia ,albania ,tirana ,Biotechnology ,TP248.13-248.65 - Abstract
Molecular diagnosis relieves patients of uncertainty, aids informed decisions about health and reproductive choices, and helps them join clinical trials or access available therapy. Genetic testing by next generation sequencing (NGS) is the suggested choice for a wide variety of disorders with heterogeneous phenotypes, alleles and loci. The development of a NGS service at MAGI Balkans, through the support of a partner, increases the availability of forefront genetic testing in Albania with great advantages for patients and their families. Here we report the NGS tests performed in collaboration with MAGI Euregio, Italy, for the diagnosis of rare genetic disease in seven probands and their families. The diseases/manifestations included ichthyosis, familial adenomatous polyposis, diabetes, syndromic craniosynostosis, fronto-temporal dementia, fragile X syndrome and ataxia. We obtained an overall detection rate of 57%. For 4/7 probands we identified a pathogenic or likely pathogenic variant, while for the others, the results did not completely explain the phenotype. All variants were confirmed by Sanger sequencing. Segregation of the variant with the affected phenotype was also evaluated.
- Published
- 2017
- Full Text
- View/download PDF
30. Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group
- Author
-
Martina Pigazzi, Barbara Buldini, Valeria Bisio, Katia Polato, Roberto Rondelli, Andrea Pession, Elena Manara, Pietro Merli, Giuseppe Basso, Franca Fagioli, Claudia Tregnago, M Frison, Matteo Zampini, Giovanni Cazzaniga, Giuseppe Menna, Andrea Biondi, Riccardo Masetti, Francesco Locatelli, Manara, E., Basso, G, Zampini, M., Buldini, B., Tregnago, C., Rondelli, R., Masetti, R., Bisio, V., Frison, M., Polato, K., Cazzaniga, G., Menna, G., Fagioli, F., Merli, P., Biondi, A., Pession, A., Locatelli, F., Pigazzi, M., Manara, E, Zampini, M, Buldini, B, Tregnago, C, Rondelli, E, Masetti, R, Bisio, V, Frison, M, Polato, K, Cazzaniga, G, Menna, G, Fagioli, F, Merli, P, Biondi, A, Pession, A, Locatelli, F, and Pigazzi, M
- Subjects
Oncology ,Myeloid ,Cancer Research ,Neoplasm, Residual ,cyclin a1 ,Epigenesis, Genetic ,0302 clinical medicine ,internal tandem duplication ,histone deacetylase inhibitor ,acute myelogenous leukemia ,minimal residual disease ,induction therapy ,risk group ,aml ,cells ,mutations ,Hematology ,Anesthesiology and Pain Medicine ,AML ,hemic and lymphatic diseases ,Gene duplication ,Child ,Leukemic ,Leukemia ,Gene Expression Regulation, Leukemic ,Myeloid leukemia ,Prognosis ,Leukemia, Myeloid, Acute ,medicine.anatomical_structure ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,030220 oncology & carcinogenesis ,Child, Preschool ,Residual ,medicine.medical_specialty ,Acute ,Disease-Free Survival ,03 medical and health sciences ,Genetic ,Internal medicine ,medicine ,Humans ,Preschool ,Retrospective Studies ,business.industry ,medicine.disease ,Minimal residual disease ,Lymphoma ,body regions ,fms-Like Tyrosine Kinase 3 ,Gene Expression Regulation ,Fms-Like Tyrosine Kinase 3 ,Immunology ,Neoplasm ,business ,030215 immunology ,Epigenesis - Abstract
Recurrent molecular markers have been routinely used in acute myeloid leukemia (AML) for risk assessment at diagnosis, whereas their post-induction monitoring still represents a debated issue. We evaluated the prognostic value and biological impact of minimal residual disease (MRD) and of the allelic ratio (AR) of FLT3-internal-tandem duplication (ITD) in childhood AML. We retrospectively screened 494 children with de novo AML for FLT3-ITD mutation, identifying 54 harboring the mutation; 51% of them presented high ITD-AR at diagnosis and had worse event-free survival (EFS, 19.2 versus 63.5% for low ITD-AR
- Published
- 2017
31. A novel complex genomic rearrangement affecting the KCNJ2 regulatory region causes a variant of Cooks syndrome
- Author
-
Elena Manara, Luigia Cinque, Orazio Palumbo, Matteo Bertelli, Lucia Micale, Simona Bianco, Mario Nicodemi, Marco Castori, Angelantonio Notarangelo, Maria Grazia Giuffrida, Laura Bernardini, Andrea M. Chiariello, Giulia Guerri, Andrea Esposito, Cinque, L., Micale, L., Manara, E., Esposito, A., Palumbo, O., Chiariello, A. M., Bianco, S., Guerri, G., Bertelli, M., Giuffrida, M. G., Bernardini, L., Notarangelo, A., Nicodemi, M., and Castori, M.
- Subjects
Genetics ,Chromosome 17 (human) ,Cardiovascular and Metabolic Diseases ,Regulatory sequence ,Breakpoint ,Locus (genetics) ,Chromosomal translocation ,Biology ,Enhancer ,Gene ,Genetics (clinical) ,Chromatin - Abstract
Cooks syndrome (CS) is an ultrarare limb malformation due to in tandem microduplications involving KCNJ2 and extending to the 5' regulatory element of SOX9. To date, six CS families were resolved at the molecular level. Subsequent studies explored the evolutionary and pathological complexities of the SOX9-KCNJ2/Sox9-Kcnj2 locus, and suggested a key role for the formation of novel topologically associating domain (TAD) by inter-TAD duplications in causing CS. Here, we report a unique case of CS associated with a de novo 1;17 translocation affecting the KCNJ2 locus. On chromosome 17, the breakpoint mapped between KCNJ16 and KCNJ2, and combined with a ~ 5 kb deletion in the 5' of KCNJ2. Based on available capture Hi-C data, the breakpoint on chromosome 17 separated KCNJ2 from a putative enhancer. Gene expression analysis demonstrated downregulation of KCNJ2 in both patient's blood cells and cultured skin fibroblasts. Our findings suggest that a complex rearrangement falling in the 5' of KCNJ2 may mimic the developmental consequences of in tandem duplications affecting the SOX9-KCNJ2/Sox9-Kcnj2 locus. This finding adds weight to the notion of an intricate role of gene regulatory regions and, presumably, the related three-dimensional chromatin structure in normal and abnormal human morphology.
- Published
- 2022
32. Investigation on the role of biallelic variants in VEGF-C found in a patient affected by Milroy-like lymphedema
- Author
-
Sylvain Mukenge, Matteo Bertelli, Andrea Brendolan, Elisa Lenti, Michael Jeltsch, Luca Aldrighetti, Sawan Kumar Jha, Daniela Negrini, Elena Manara, Veli-Matti Leppänen, Marco Catena, CAN-PRO - Translational Cancer Medicine Program, Michael Jeltsch / Principal Investigator, Research Programs Unit, University of Helsinki, Kari Alitalo / Principal Investigator, Helsinki One Health (HOH), INDIVIDRUG - Individualized Drug Therapy, Mukenge, S., Jha, S. K., Catena, M., Manara, E., Leppanen, V. -M., Lenti, E., Negrini, D., Bertelli, M., Brendolan, A., Jeltsch, M., and Aldrighetti, L.
- Subjects
0301 basic medicine ,Proband ,Male ,lymphatic system ,Milroy disease ,mutation ,primary lymphedema ,VEGF-C ,VEGF‐C ,Vascular Endothelial Growth Factor C ,Disease ,030105 genetics & heredity ,medicine.disease_cause ,GROWTH FACTOR-C ,Lymphedema ,Child ,Genetics (clinical) ,Genetics ,Mutation ,medicine.diagnostic_test ,1184 Genetics, developmental biology, physiology ,Middle Aged ,Pedigree ,Phenotype ,Original Article ,Female ,LYMPHANGIOGENESIS ,Adult ,lcsh:QH426-470 ,Mutation, Missense ,MECHANISMS ,03 medical and health sciences ,medicine ,Humans ,Primary lymphedema ,Molecular Biology ,Alleles ,Genetic testing ,business.industry ,Original Articles ,medicine.disease ,FLT4 ,lcsh:Genetics ,030104 developmental biology ,Etiology ,3111 Biomedicine ,business - Abstract
Background Milroy‐like disease is the diagnostic definition used for patients with phenotypes that resemble classic Milroy disease (MD) but are negative to genetic testing for FLT4. In this study, we aimed at performing a genetic characterization and biochemical analysis of VEGF‐C variations found in a female proband born with congenital edema consistent with Milroy‐like disease. Methods The proband underwent next‐generation sequencing‐based genetic testing for a panel of genes associated with known forms of hereditary lymphedema. Segregation analysis was performed on family members by direct sequencing. In vitro studies were performed to evaluate the role of a novel identified variant. Results Two VEGF‐C variations were found in the proband, a novel p.(Ser65Arg) and a pathogenic c.148‐3_148‐2delCA, of paternal and maternal origin, respectively. Functional characterization of the p.(Ser65Arg) variation in vitro showed alterations in VEGF‐C processing. Conclusions Our findings reveal an interesting case in which biallelic variants in VEGF‐C are found in a patient with Milroy‐like lymphedema. These data expand our understanding of the etiology of congenital Milroy‐like lymphedema., A genetic and biochemical analysis of VEGF‐C variations were performed on a female proband affected by primary lymphedema of the right lower limb and on her entire family. Biallelic variants of VEGF‐C variations were found in the proband: a novel p.(Ser65Arg) and a pathogenic c.148‐3_148‐2del, of paternal and maternal origin, respectively. Clinical examination of the family by lymphoscintigraphy as well as biochemical analysis show that both variants are required to the development of the proband Milroy‐like lymphedema.
- Published
- 2020
33. Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema
- Author
-
Paolo Enrico Maltese, Astrit Dautaj, Karen L. Herbst, Pietro Chiurazzi, Valerio Marino, Sandro Michelini, Michele Pinelli, Matteo Bertelli, Elena Manara, Daniele Dell'Orco, Mirko Baglivo, Alessandro Fiorentino, Michelini, S., Chiurazzi, P., Marino, V., Dell'Orco, D., Manara, E., Baglivo, M., Fiorentino, A., Maltese, P. E., Pinelli, M., Herbst, K. L., Dautaj, A., and Bertelli, M.
- Subjects
Models, Molecular ,Candidate gene ,subcutaneous fat ,AKR1C1 ,Protein Conformation ,Reductase ,whole exome sequencing ,lcsh:Chemistry ,Loss of Function Mutation ,Medicine ,Missense mutation ,lcsh:QH301-705.5 ,Spectroscopy ,Exome sequencing ,Progesterone ,General Medicine ,Middle Aged ,Computer Science Applications ,molecular modelling ,20-alpha-Dihydroprogesterone ,Pedigree ,Female ,Human ,Adult ,medicine.medical_specialty ,Mutation, Missense ,Molecular Dynamics Simulation ,Catalysis ,Article ,Inorganic Chemistry ,Internal medicine ,Exome Sequencing ,Humans ,aldo-keto reductase activity ,Physical and Theoretical Chemistry ,Molecular Biology ,20-Hydroxysteroid Dehydrogenases ,Aged ,Aldo-keto reductase ,business.industry ,Organic Chemistry ,steroid hormone metabolism ,lipedema ,Endocrinology ,lcsh:Biology (General) ,lcsh:QD1-999 ,Hydroxyprogesterone ,20-Hydroxysteroid Dehydrogenase ,business ,Steroid hormone metabolism - Abstract
Lipedema is an often underdiagnosed chronic disorder that affects subcutaneous adipose tissue almost exclusively in women, which leads to disproportionate fat accumulation in the lower and upper body extremities. Common comorbidities include anxiety, depression, and pain. The correlation between mood disorder and subcutaneous fat deposition suggests the involvement of steroids metabolism and neurohormones signaling, however no clear association has been established so far. In this study, we report on a family with three patients affected by sex-limited autosomal dominant nonsyndromic lipedema. They had been screened by whole exome sequencing (WES) which led to the discovery of a missense variant p.(Leu213Gln) in AKR1C1, the gene encoding for an aldo-keto reductase catalyzing the reduction of progesterone to its inactive form, 20-&alpha, hydroxyprogesterone. Comparative molecular dynamics simulations of the wild-type vs. variant enzyme, corroborated by a thorough structural and functional bioinformatic analysis, suggest a partial loss-of-function of the variant. This would result in a slower and less efficient reduction of progesterone to hydroxyprogesterone and an increased subcutaneous fat deposition in variant carriers. Overall, our results suggest that AKR1C1 is the first candidate gene associated with nonsyndromic lipedema.
- Published
- 2020
34. Vascular anomalies: Molecular bases, genetic testing and therapeutic approaches
- Author
-
Raul Mattassi, Elena Manara, Alice Bruson, Byung-Boong Lee, Sandro Michelini, Stefano Paolacci, Alessandra Zulian, Matteo Bertelli, Bruno Amato, Paolacci, S., Zulian, A., Bruson, A., Manara, E., Michelini, S., Mattassi, R. E., Lee, B. -B., Amato, B., and Bertelli, M.
- Subjects
Genetic Markers ,Vascular Malformations ,Genetic Association Studie ,030204 cardiovascular system & hematology ,030230 surgery ,Bioinformatics ,DNA sequencing ,03 medical and health sciences ,Germ-line mutation ,0302 clinical medicine ,Targeted ngs ,Genetic Marker ,Humans ,Medicine ,Genetic Predisposition to Disease ,Genetic Testing ,Genetic Association Studies ,Genetic testing ,Pharmacology ,Vascular Malformation ,medicine.diagnostic_test ,business.industry ,Mechanism (biology) ,Genetic heterogeneity ,Genetic Variation ,High-Throughput Nucleotide Sequencing ,Vascular Tumors ,Etiology ,Therapy ,Cardiology and Cardiovascular Medicine ,business ,Genetic diagnosis ,Human - Abstract
INTRODUCTION Vascular anomalies encompass an extremely heterogeneous group of congenital abnormalities of the vascular system. They include vascular tumors and malformations and have a prevalence of 4.5%. Vascular anomalies are frequently sporadic and associated with somatic mutations and/or a double-hit mechanism and are characterized by considerable phenotypic and genetic heterogeneity. The aim of this review was to provide a genetic description of vascular anomalies, the sequencing technologies used for their diagnosis and the drugs that may potentially be used for their treatment. EVIDENCE ACQUISITION PubMed, OMIM, Orphanet, Genetic Testing Registry and ClinicalTrials.gov were searched for monogenic vascular anomalies in order to evaluate the genetic tests (based on sequencing) currently used for their diagnosis, and for any drugs that could be useful to treat them. EVIDENCE SYNTHESIS From the search of the clinical synopsis section of OMIM and PubMed for vascular anomalies we selected 19 disorders with a known molecular etiology. From the search for pharmacological trials and therapies in the ClinicalTrials.gov and PubMed databases we selected 87 drugs. CONCLUSIONS Most genetic tests with validated clinical utility are based on a next generation sequencing (NGS) approach. Targeted NGS is indeed the best approach for the analysis of disorders with complex phenotypes and genetics and involvement of somatic mutations. Genetic diagnosis provides data for determine genotype-phenotype correlations, segregation and recurrence risk in families, and new targets for gene- or mutation-specific pharmacological therapies. Improvement of diagnostic techniques is needed to offer patients appropriate care, more focused follow-up, and hopefully drugs to treat their disorders.
- Published
- 2019
35. Multiplicative representations of surface groups
- Author
-
MANARA, ELIA, Manara, E, and KUHN, MARIA GABRIELLA
- Subjects
tempered ,group ,surface ,representation ,MAT/05 - ANALISI MATEMATICA ,C*-algebra - Abstract
Un gruppo di superficie è (isomorfo) al gruppo fondamentale di una superficie orientabile chiusa di genere k (maggiore o uguale a 2). È uno small cancellation group e quindi iperbolico; il suo grafo di Cayley è isomorfo a una tassellatura del piano iperbolico fatta di 2k-goni iperbolici. È possibile definire alcuni sottoinsiemi del grafo di Cayley, detti “coni”, su cui il gruppo agisce con un numero finito di orbite, chiamate “cono tipi”. Una rappresentazione moltiplicativa di un gruppo di superficie è una rappresentazione unitaria definita sullo spazio di Hilbert delle funzioni moltiplicative. Una funzione moltiplicativa su un gruppo di superfici ha valori vettoriali ed è definita mediante la scelta di un insieme di parametri, chiamato “sistema di matrici”. Due funzioni moltiplicative sono equivalenti se differiscono solo su un numero finito di elementi. Si può definire un prodotto interno sulle classi di equivalenza di funzioni moltiplicative. Dimostriamo che almeno per il caso di un gruppo di superficie del genere 2 ed una scelta del sistemi di matrici il prodotto interno non è identicamente nullo; dato che esso non dipende dalla scelta dei rappresentanti per le funzioni moltiplicative, è ben definito. Questa dimostrazione si basa sull'irriducibilità di una certa matrice associata alla geometria del grafo di Cayley; in particolare, un certo autovalore Perron-Frobenius deve essere semplice. Una rappresentazione moltiplicativa agisce semplicemente per traslazione sinistra sul completamento dello spazio di Hilbert dello spazio delle funzioni moltiplicative rispetto al prodotto interno sopra menzionato. La rappresentazione così definita è temperata: mostriamo che i coefficienti di matrice della rappresentazione regolare approssimano quelli della rappresentazione moltiplicativa. Con il termine “rappresentazione sul bordo” intendiamo una rappresentazione di una certa C*-algebra prodotto incrociato, ottenuta dall'azione del gruppo di superficie sulla C*-algebra delle funzioni continue sul bordo - che è omeomorfo ad una circonferenza. Una rappresentazione sul bordo è data da una rappresentazione unitaria del gruppo e una rappresentazione della C*-algebra che soddisfi una condizione di covarianza. Definiamo una famiglia di sottospazi (indicizzata da una quantità reale) di uno spazio di funzioni di quadrato integrabile con valori vettoriali sul gruppo e agiamo su questi sottospazi per traslazione a sinistra con il gruppo e per moltiplicazione con le funzioni continue sulla compattificazione del gruppo di superficie (il gruppo unito al suo bordo). Otteniamo alcune rappresentazioni del gruppo e dell'algebra che soddisfano la covarianza e mostriamo che la famiglia ha una sottosuccessione convergente. Mostriamo quindi che l'azione della C*-algebra coinvolge solo i valori delle funzioni sul bordo: otteniamo quindi una rappresentazione sul bordo. Mostriamo, inoltre, che il limite così ottenuto non dipende dalla sottosuccessione tendente a zero. Abbiamo così una rappresentazione sul bordo ben definita. Mostriamo che la parte unitaria di questa rappresentazione sul bordo è equivalente alla rappresentazione moltiplicativa: infatti, le loro funzioni di tipo positivo coincidono. Infine, mostriamo che la rappresentazione sul bordo è irriducibile. Questo risultato si ottiene sfruttando l'unicità (a meno di prodotto per una costante positiva) dell'autovalore di Perron-Frobenius ottenuto nella dimostrazione della buona positura del prodotto interno: dimostriamo che qualsiasi proiezione che commuta sia con la rappresentazione del gruppo che con la rappresentazione dell’algebra permette di definire un autovettore della stessa matrice corrispondente all'autovalore di Perron-Frobenius. Quindi, dopo alcuni calcoli, otteniamo che la proiezione considerata deve essere banale. Da una versione del Lemma di Schur segue che la rappresentazione del prodotto incrociato è irriducibile. A surface group is (isomorphic to) the fundamental group of a closed orientable surface of genus k greater or equal than 2. It is a small cancellation group (hence hyperbolic); its Cayley graph is isomorphic to a tiling of the hyperbolic plane by 2k-gons. One can define certain subsets of the Cayley graph called cones. The group acts on the set of cones with finitely many orbits, called cone types. A multiplicative representation of a surface group is a unitary representation defined on the Hilbert space of multiplicative functions. A multiplicative function on a surface group is a vector-valued function defined through the choice of a set of parameters, called matrix system. Two multiplicative functions are equivalent if they differ only on finitely many elements. An inner product can be defined for equivalence classes of multiplicative functions. We prove that at least for the case of a surface group of genus 2 and a choice of the matrices as non-negative scalars the inner product is not identically zero; thus, since it does not depend on the representatives for the multiplicative functions, it is well posed. This proof relies on the irreducibility of a certain matrix associated with the geometry of the Cayley graph; in particular, a certain Perron-Frobenius eigenvalue must be simple. A multiplicative representation then simply acts by left translation on the Hilbert space completion of the space of multiplicative functions with respect to the inner product above mentioned. The representation thus defined is tempered: we show that the matrix coefficients of the regular representation approximate those of the multiplicative representation. By the term boundary representation, we mean a representation of a certain crossed product C*-algebra, obtained by the action of the surface group on the C*-algebra of continuous functions on its boundary – which is homeomorphic to the unit circle. Such a boundary representation is given by a unitary representation of the group and a representation of the C*-algebra satisfying a covariance condition. We define a family of subspaces (indexed by a real quantity) of a space of vector-valued square integrable functions on the group and we act on these subspaces by left translation with the group and by multiplication with continuous functions on the compactification of the surface group (the group united with its boundary). Thus, we get some representations of the group and the algebra satisfying covariance and we show that the family has a limit for a subsequence of the indexes tending to zero. We then show that the action of the C*-algebra involves only the values of the functions on the boundary. Hence, we get a boundary representation. We show, moreover, that the limit thus obtained does not depend on the subsequence tending to zero. Hence, we get a well-defined representation of the crossed product C*-algebra. We show that the unitary part of this boundary representation is equivalent to the multiplicative representation: in fact, their functions of positive type coincide. Finally, we show that the boundary representation is irreducible. This result is achieved by exploiting the uniqueness (up to scaling) of the Perron-Frobenius eigenvalue obtained in the proof of the well-posedness of the inner product: in fact, we show that any projection intertwining both the group representation and the algebra representation allows to define an eigenvector of the same matrix corresponding to the Perron-Frobenius eigenvalue. Thus, after some calculations, we get that the projection considered must be trivial. By a version of Schur’s Lemma, this yields the irreducibility of the crossed product representation.
- Published
- 2018
36. Clinical and molecular findings in an Albanian family with familial adenomatous polyposis
- Author
-
P E Maltese, G Di Saverio, E Manara, F Fanelli, N Capodicasa, D Guraj, I Shehaj, B Amato, A Babameto Laku, S Michelini, M Bertelli, Maltese, P. E., Di Saverio, G., Manara, E., Fanelli, F., Capodicasa, N., Guraj, D., Shehaj, I., Amato, B., Babameto-Laku, A., Michelini, S., and Bertelli, M.
- Subjects
Familial adenomatous polyposi ,Genetics ,FAP ,General Medicine ,Colorectal cancer ,Molecular Biology ,APC - Published
- 2017
37. NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group
- Author
-
Valentina Salsi, Anna Leszl, Matteo Zampini, Cristina Mecucci, Vincenzo Zappavigna, D. Di Giacomo, Marco Togni, Elena Manara, A Di Meglio, Andrea Pession, Giuseppe Basso, Valeria Bisio, Claudia Tregnago, Sonia Minuzzo, Riccardo Masetti, Roberto Rondelli, Francesco Locatelli, Martina Pigazzi, Bisio, V., Zampini, M., Tregnago, C., Manara, E., Salsi, V., Di Meglio, A., Masetti, R., Togni, M., Di Giacomo, D., Minuzzo, S., Leszl, A., Zappavigna, V., Rondelli, R., Mecucci, C., Pession, A., Locatelli, F., Basso, G., and Pigazzi, M.
- Subjects
0301 basic medicine ,Cancer Research ,Oncogene Proteins, Fusion ,Translocation, Genetic ,Fusion gene ,0302 clinical medicine ,AML ,Hematology ,Anesthesiology and Pain Medicine ,hemic and lymphatic diseases ,Antineoplastic Combined Chemotherapy Protocols ,Mercaptopurine ,Cytarabine ,Myeloid leukemia ,Prognosis ,Up-Regulation ,Leukemia ,Haematopoiesis ,Leukemia, Myeloid, Acute ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,Oncology ,Vincristine ,030220 oncology & carcinogenesis ,Stem cell ,Human ,medicine.medical_specialty ,Nuclear Pore Complex Protein ,Prognosi ,Down-Regulation ,03 medical and health sciences ,Internal medicine ,medicine ,Biomarkers, Tumor ,Asparaginase ,Humans ,neoplasms ,Cyclophosphamide ,Antineoplastic Combined Chemotherapy Protocol ,business.industry ,Daunorubicin ,medicine.disease ,Lymphoma ,Nuclear Pore Complex Proteins ,030104 developmental biology ,Methotrexate ,Immunology ,Mutation ,Prednisone ,business - Abstract
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group
- Published
- 2017
38. Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing
- Author
-
Salvatore Serravalle, Andrea Pession, Annalisa Astolfi, Giuseppe Basso, Valentina Indio, Marco Togni, Riccardo Masetti, Franco Locatelli, Elena Manara, Martina Pigazzi, Valeria Bisio, Daniele Zama, Carmelo Rizzari, Togni, M, Masetti, R, Pigazzi, M, Astolfi, A, Zama, D, Indio, V, Serravalle, S, Manara, E, Bisio, V, Rizzari, C, Basso, G, Pession, A, Locatelli, F, Togni, Marco, Masetti, Riccardo, Pigazzi, Martina, Astolfi, Annalisa, Zama, Daniele, Indio, Valentina, Serravalle, Salvatore, Manara, Elena, Bisio, Valeria, Rizzari, Carmelo, Basso, Giuseppe, Pession, Andrea, and Locatelli, Franco
- Subjects
Myeloid ,Male ,medicine.medical_specialty ,Cancer Research ,NUP98 gene fusion ,Translocation ,Chromosomal translocation ,Biology ,Acute ,Translocation, Genetic ,NO ,Pediatric acute myeloid leukemia ,Fusion gene ,Cohort Studies ,Cytogenetics ,NUP98 gene fusions ,PHD domain ,Hematology ,Oncology ,Molecular Biology ,Genetic ,NUP98/PHF23 Fusion Gene ,Child ,Child, Preschool ,Female ,Gene Fusion ,Humans ,Leukemia, Myeloid, Acute ,Transcriptome ,hemic and lymphatic diseases ,Internal medicine ,medicine ,Preschool ,Letter to the Editor ,neoplasms ,Leukemia ,Myeloid leukemia ,medicine.disease ,medicine.anatomical_structure ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,Cancer research - Abstract
The genomic landscape of children with acute myeloid leukemia (AML) who do not carry any cytogenetic abnormality (CN-AML) is particularly heterogeneous and challenging, being characterized by different clinical outcomes. To provide new genetic insights into this AML subset, we analyzed through RNA-seq 13 pediatric CN-AML cases, corroborating our findings in an independent cohort of 168 AML patients enrolled in the AIEOP AML 2002/01 study. We identified a chimeric transcript involving NUP98 and PHF23, resulting from a cryptic t(11;17)(p15;p13) translocation, demonstrating, for the first time, that NUP98-PHF23 is a novel recurrent (2.6 %) abnormality in pediatric CN-AML.
- Published
- 2015
39. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia
- Author
-
Sanja Aveic, Franco Locatelli, Riccardo Masetti, Claudia Tregnago, Silvia Bresolin, Giuseppe Basso, Elena Manara, Martina Pigazzi, Emma Baron, Valeria Bisio, Manara E, Baron E, Tregnago C, Aveic S, Bisio V, Bresolin S, Masetti R, Locatelli F, Basso G, and Pigazzi M
- Subjects
Transcriptional Activation ,Oncogene Proteins, Fusion ,Immunology ,Cell ,Kinesins ,Biology ,Myosins ,Biochemistry ,Translocation, Genetic ,Proto-Oncogene Proteins p21(ras) ,hemic and lymphatic diseases ,Cell Line, Tumor ,medicine ,Humans ,Gene Silencing ,Child ,neoplasms ,PEDIATRIC AML ,Ras Inhibitor ,Cell Nucleus ,Oncogene ,Chromosomes, Human, Pair 11 ,RUNX1T1 ,Myeloid leukemia ,Cell Biology ,Hematology ,medicine.disease ,Leukemia ,Protein Transport ,medicine.anatomical_structure ,Cell Transformation, Neoplastic ,RISK MYELODYSPLASTIC SYNDROME, PDZ DOMAIN, FARNESYLTRANSFERASE INHIBITOR, GENE REARRANGEMENTS, MLL TRANSLOCATIONS, CELL-ADHESION, AF-6, PROTEIN, TIPIFARNIB, MUTATIONS ,Ras Signaling Pathway ,N/A ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,Leukemia, Myeloid ,Cancer research ,Tipifarnib ,Chromosomes, Human, Pair 6 ,Myeloid-Lymphoid Leukemia Protein ,medicine.drug - Abstract
A rare location, t(6;11)(q27;q23) (MLL-AF6), is associated with poor outcome in childhood acute myeloid leukemia (AML). The described mechanism by which MLL-AF6, through constitutive self-association and in cooperation with DOT-1L, activates aberrant gene expression does not explain the biological differences existing between t(6;11)-rearranged and other MLL-positive patients nor their different clinical outcome. Here, we show that AF6 is expressed in the cytoplasm of healthy bone marrow cells and controls rat sarcoma viral oncogene (RAS)-guanosine triphosphate (GTP) levels. By contrast, in MLL-AF6-rearranged cells, AF6 is found localized in the nucleus, leading to aberrant activation of RAS and of its downstream targets. Silencing MLL-AF6, we restored AF6 localization in the cytoplasm, thus mediating significant reduction of RAS-GTP levels and of cell clonogenic potential. The rescue of RAS-GTP levels after MLL-AF6 and AF6 co-silencing confirmed that MLL-AF6 oncoprotein potentiates the activity of the RAS pathway through retention of AF6 within the nucleus. Exposure of MLL-AF6-rearranged AML blasts to tipifarnib, a RAS inhibitor, leads to cell autophagy and apoptosis, thus supporting RAS targeting as a novel potential therapeutic strategy in patients carrying t(6;11). Altogether, these data point to a novel role of the MLL-AF6 chimera and show that its gene partner, AF6, is crucial in AML development.
- Published
- 2014
40. MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation
- Author
-
Silvia Bresolin, Er-Chieh Cho, Elena Manara, Riccardo Masetti, Emanuela Giarin, Martina Pigazzi, Kathleen M. Sakamoto, Claudia Tregnago, Alessandra Beghin, Emma Baron, Giuseppe Basso, Dinesh S. Rao, Pigazzi M, Manara E, Bresolin S, Tregnago C, Beghin A, Baron E, Giarin E, Cho EC, Masetti R, Rao DS, Sakamoto KM, and Basso G
- Subjects
Myeloid ,p300-CBP coactivator family ,Mice, SCID ,Mice ,0302 clinical medicine ,Mice, Inbred NOD ,hemic and lymphatic diseases ,Myeloid Cells ,Child ,Cyclic AMP Response Element-Binding Protein ,Promoter Regions, Genetic ,Cells, Cultured ,Mice, Knockout ,0303 health sciences ,biology ,Juvenile myelomonocytic leukemia ,Gene Expression Regulation, Leukemic ,Myeloid leukemia ,MicroRNA ,Hematology ,MicroRNA-34b ,3. Good health ,Leukemia ,medicine.anatomical_structure ,Cell Transformation, Neoplastic ,Leukemia, Myeloid ,030220 oncology & carcinogenesis ,Child, Preschool ,Acute Disease ,Myelopoiesis ,ACUTE MYELOID LEUKEMIA ,Interleukin Receptor Common gamma Subunit ,Adolescent ,HL-60 Cells ,CREB ,03 medical and health sciences ,medicine ,Animals ,Humans ,030304 developmental biology ,Myelodysplastic syndromes ,Gene Expression Profiling ,Infant, Newborn ,Infant ,DNA Methylation ,medicine.disease ,MicroRNAs ,Myelodysplastic Syndromes ,Cancer research ,biology.protein ,Original Articles and Brief Reports - Abstract
MicroRNA-34b down-regulation in acute myeloid leukemia was previously shown to induce CREB overexpression, thereby causing leukemia proliferation in vitro and in vivo. The role of microRNA-34b and CREB in patients with myeloid malignancies has never been evaluated. We examined microRNA-34b expression and the methylation status of its promoter in cells from patients diagnosed with myeloid malignancies. We used gene expression profiling to identify signatures of myeloid transformation. We established that microRNA-34b has suppressor ability and that CREB has oncogenic potential in primary bone marrow cell cultures and in vivo. MicroRNA-34b was found to be up-regulated in pediatric patients with juvenile myelomonocytic leukemia (n=17) and myelodysplastic syndromes (n=28), but was down-regulated in acute myeloid leukemia patients at diagnosis (n=112). Our results showed that hypermethylation of the microRNA-34b promoter occurred in 66% of cases of acute myeloid leukemia explaining the low microRNA-34b levels and CREB overexpression, whereas preleukemic myelodysplastic syndromes and juvenile myelomonocytic leukemia were not associated with hypermethylation or CREB overexpression. In paired samples taken from the same patients when they had myelodysplastic syndrome and again during the subsequent acute myeloid leukemia, we confirmed microRNA-34b promoter hypermethylation at leukemia onset, with 103 CREB target genes differentially expressed between the two disease stages. This subset of CREB targets was confirmed to associate with high-risk myelodysplastic syndromes in a separate cohort of patients (n=20). Seventy-eight of these 103 CREB targets were also differentially expressed between healthy samples (n=11) and de novo acute myeloid leukemia (n=72). Further, low microRNA-34b and high CREB expression levels induced aberrant myelopoiesis through CREB-dependent pathways in vitro and in vivo. In conclusion, we suggest that microRNA-34b controls CREB expression and contributes to myeloid transformation from both healthy bone marrow and myelodysplastic syndromes. We identified a subset of CREB target genes that represents a novel transcriptional network that may control myeloid transformation.
- Published
- 2013
41. Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group
- Author
-
Valeria Bisio, Martina Pigazzi, Andrea Pession, Riccardo Masetti, Franco Locatelli, Marco Zecca, Sanja Aveic, Giuseppe Menna, Elena Manara, Giuseppe Basso, Pigazzi M, Manara E, Bisio V, Aveic S, Masetti R, Menna G, Zecca M, Pession A, Locatelli F, and Basso G
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Immunology ,Pediatric acute myeloid leukemia ,pediatric acute myeloid leukemia ,Myeloid leukemia ,Cell Biology ,Hematology ,Disease ,Gene deletion ,Biochemistry ,hemic and lymphatic diseases ,Internal medicine ,medicine ,business - Abstract
To the editor: Acute myeloid leukemia (AML) is a heterogeneous disease with known specific recurrent genetic aberrations. The continuous and increasing identification of new genetic lesions has permitted the identification of new subgroups of patients with different prognosis.[1][1] In the present
- Published
- 2012
42. Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia
- Author
-
Andrea Pession, Alessandra Beghin, Roberto Rondelli, Martina Pigazzi, Franco Locatelli, Riccardo Masetti, Giuseppe Basso, Francesco Martinolli, Elena Manara, Franca Fagioli, Pigazzi M, Masetti R, Martinolli F, Manara E, Beghin A, Rondelli R, Locatelli F, Fagioli F, Pession A, and Basso G
- Subjects
Myeloid ,GENE EXPRESSION ,Immunology ,cute granulocytic leukemia ,Disease ,Acute ,Biochemistry ,hemic and lymphatic diseases ,Medicine ,Humans ,neoplasms ,Gene ,Leukemia ,business.industry ,Childhood Acute Myeloid Leukemia ,childhood leukemia ,Myeloid leukemia ,Hematology ,Cell Biology ,Neoplasm Proteins ,Leukemia, Myeloid, Acute ,fms-Like Tyrosine Kinase 3 ,Tandem Repeat Sequences ,ERG gene ,business ,Erg - Abstract
To the editor: Childhood acute myeloid leukemia (AML) is a heterogeneous disease, in terms of genetic/molecular abnormalities resulting into marked differences in outcome.[1][1] A myriad of proteins have been suggested aberrantly regulated in AML, and Ets-related gene ( ERG , 21q22) expression in
- Published
- 2012
43. Occupational burnout and job satisfaction among community pharmacists.
- Author
-
Katsogiannis I, Manara E, Peletidi A, Bistaraki A, Constantinides T, and Kontogiorgis C
- Abstract
Introduction: Community pharmacists (CPs) are the most accessible healthcare professionals in primary care due to pharmacies' open-door policy and convenience, resulting in high patient and prescription volumes, and numerous free-of-charge consultations. Therefore, they are at high risk for burnout., Objectives: The primary objective of this study was to assess the levels of burnout among community pharmacists in Greece, marking the first investigation of its kind within the country. Additionally, this study aimed to explore potential correlations between demographic variables and other health-related factors with burnout scores ., Methods: This study used a quantitative cross-sectional design involving two validated questionnaires(the Greek version of Maslach (MBI) questionnaire and the SF-36 questionnaire). Prior to data collection, all the relevant documentation was approved by the Metropolitan College Research Ethics Committee and was adopted under the auspices of the Panhellenic Pharmaceutical Association. Random sampling was used. Data collection period was July to August 2022., Results: A total of 368 responses were included in the analysis, with the majority being pharmacy-owners ( n = 292, 79.3%). Notably, a significant proportion of respondents were female practitioners working within community pharmacy settings ( n = 230, 62.5%). Analysis revealed that the sample exhibited low levels of personal achievement (M = 30.99, SD = 6.41), high levels of emotional exhaustion (M = 41.73, SD = 6.94), and moderate levels of depersonalization (M = 23.38, SD = 3.78), indicative of substantial occupational burnout. Furthermore, gender had a discernible impact on depersonalization, with women scoring higher than men ( t = -3.29, p < 0.01). Pharmacists who identified medicine shortages as their primary challenge in daily practice reported lower emotional burnout and depersonalization, albeit with a diminished sense of accomplishment ( t = -2.62, p < 0.01 ) ., Conclusions: This study sheds light on burnout levels and health-related quality of life among community pharmacists in Greece., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
44. Established but not spreading: the tropical invasive snail Melanoides tuberculata in a geothermally warmed channel in temperate Southern Pampas.
- Author
-
Seuffert ME, Tamburi NE, Saveanu L, Maldonado MA, Manara E, Gurovich FM, Tiecher MJ, Burela S, and Martín PR
- Subjects
- Animals, Male, Fresh Water, Food Chain, Argentina, Snails, Lepidoptera
- Abstract
Melanoides tuberculata is a freshwater snail native to Old World tropical areas but has invaded tropical and subtropical regions around the world. In Argentina, populations established in natural environments were reported from northeastern tropical provinces. Here we report for the first time the presence of M. tuberculata in a geothermally warmed channel in temperate Southern Pampas. We mapped its distribution in the channel, searched for its presence in five nearby basins, estimated the risk of establishment and expansion in Argentina with distribution models and analyzed shape variation through geometric morphometrics. Melanoides tuberculata was recorded exclusively in the channel in sites with temperatures between 20 and 40°C, with almost no overlap with other snails. No evidence of M. tuberculata was found in nearby basins. The distribution model predicted that only northernmost areas from Argentina are suitable for this species, where it could impact snail communities and food webs if introduction through the aquarium trade is not prevented. The absence of males indicates parthenogenetic reproduction and probably a recent invasion. Shell shape variation in this population, 15 % of which is attributable to allometry, encompasses the shapes of specimens from other South American populations, suggesting that all belong to the same lineage.
- Published
- 2023
- Full Text
- View/download PDF
45. CDH5 , a Possible New Candidate Gene for Genetic Testing of Lymphedema.
- Author
-
Michelini S, Ricci M, Amato B, Gentileschi S, Veselenyiova D, Kenanoglu S, Fiorentino A, Kurti D, Baglivo M, Manara E, Basha SH, Priya S, Krajcovic J, Dundar M, Belgrado JP, Dautaj A, and Bertelli M
- Subjects
- Humans, Endothelial Cells, Genetic Testing, Cadherins genetics, High-Throughput Nucleotide Sequencing, Lymphedema diagnostic imaging, Lymphedema genetics, Lymphatic Abnormalities genetics
- Abstract
Background: Expressed by endothelial cells, CDH5 is a cadherin involved in vascular morphogenesis and in the maintenance of vascular integrity and lymphatic function. The main purpose of our study was to identify distinct variants of the CDH5 gene that could be associated with lymphatic malformations and predisposition for lymphedema. Methods and Results: We performed Next Generation Sequencing of the CDH5 gene in 235 Italian patients diagnosed with lymphedema but who tested negative for variants in known lymphedema genes. We detected six different variants in CDH5 five missense and one nonsense. We also tested available family members of the probands. For family members who carried the same variant as the proband, we performed lymphoscintigraphy to detect any lymphatic system abnormalities. Variants were modeled in silico. The results showed that CDH5 variants may contribute to the onset of lymphedema, although further in vitro studies are needed to confirm this hypothesis. Conclusions: Based on our findings, we propose CDH5 as a new gene that could be screened in patients with lymphedema to gather additional evidence.
- Published
- 2022
- Full Text
- View/download PDF
46. Characterization of a Novel Frameshift Mutation Within the TRPS1 Gene Causing Trichorhinophalangeal Syndrome Type 1 in a Kindred Cypriot Family.
- Author
-
Ergoren MC, Akcan N, Manara E, Paolacci S, Fahrioğlu U, Betmezoglu M, Bundak R, Mocan G, Temel SG, and Bertelli M
- Subjects
- DNA-Binding Proteins genetics, Fingers abnormalities, Hair Diseases, Langer-Giedion Syndrome, Nose abnormalities, Repressor Proteins genetics, Transcription Factors genetics, Codon, Nonsense, Frameshift Mutation
- Abstract
Trichorhinophalangeal syndrome (TRPS) is an extremely rare autosomal dominant multisystem disorder characterized by craniofacial and skeletal abnormalities. Three subtypes of TRPS have been described: TRPS type I, TRPS type II, and TRPS type III. Mutations in the TRPS1 gene can cause both TRPS type I and TRPS type III. Therefore, the genotype-phenotype correlation is crucial to determine the subtype. The current family study from Cyprus involves affected patients from 4 generations who presented with alopecia, unoperated umbilical hernia, caput quadratum, long philtrum, depressed nasal bridge, frontal bossing, pes planus, beaked nose, and some deformities in hands and feet. Sequence analysis of the TRPS1 gene revealed a novel c.2854_2858del (p.Asn952ArgfsTer2) frameshift variant leading to a premature stop codon. To the best of our knowledge, we report here the first case of a Turkish Cypriot family of 4 generations with a novel frameshift mutation leading to truncated protein in the TRPS1 gene causing TRPS type I clinical phenotype. Overall, as the genotype and phenotype correlation in TRPSI is still uncertain and complex, the present outcome can enhance our knowledge of this complicated, rare, and severe genetic disorder., Competing Interests: The authors declare no conflict of interest., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
47. A next generation sequencing gene panel for use in the diagnosis of anorexia nervosa.
- Author
-
Ceccarini MR, Precone V, Manara E, Paolacci S, Maltese PE, Benfatti V, Dhuli K, Donato K, Guerri G, Marceddu G, Chiurazzi P, Dalla Ragione L, Beccari T, and Bertelli M
- Subjects
- 3',5'-Cyclic-GMP Phosphodiesterases genetics, Animals, Cyclooxygenase 2 genetics, Female, Humans, Male, Mice, Mitochondrial Membrane Transport Proteins genetics, Mutation, Protein Tyrosine Phosphatase, Non-Receptor Type 22 genetics, Anorexia Nervosa diagnosis, Anorexia Nervosa genetics, High-Throughput Nucleotide Sequencing
- Abstract
Purpose: The aim of this study was to increase knowledge of genes associated with anorexia nervosa (AN) and their diagnostic offer, using a next generation sequencing (NGS) panel for the identification of genetic variants. The rationale underlying this test is that we first analyze the genes associated with syndromic forms of AN, then genes that were found to carry rare variants in AN patients who had undergone segregation analysis, and finally candidate genes intervening in the same molecular pathways or identified by GWAS or in mouse models., Methods: We developed an NGS gene panel and used it to screen 68 Italian AN patients (63 females, 5 males). The panel included 162 genes. Family segregation study was conducted on available relatives of probands who reported significant genetic variants., Results: In our analysis, we found potentially deleterious variants in 2 genes (PDE11A and SLC25A13) associated with syndromic forms of anorexia and predicted deleterious variants in the following 12 genes: CD36, CACNA1C, DRD4, EPHX2, ESR1, GRIN2A, GRIN3B, LRP2, NPY4R, PTGS2, PTPN22 and SGPP2. Furthermore, by Sanger sequencing of the promoter region of NNAT, we confirmed the involvement of this gene in the pathogenesis of AN. Family segregation studies further strengthened the possible causative role of CACNA1C, DRD4, GRIN2A, PTGS2, SGPP2, SLC25A13 and NNAT genes in AN etiology., Conclusion: The major finding of our study is the confirmation of the involvement of the NNAT gene in the pathogenesis of AN; furthermore, this study suggests that NGS-based testing can play an important role in the diagnostic evaluation of AN, excluding syndromic forms and increasing knowledge of the genetic etiology of AN., Level of Evidence: Level I, experimental study., (© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Published
- 2022
- Full Text
- View/download PDF
48. A Multi-Gene Panel to Identify Lipedema-Predisposing Genetic Variants by a Next-Generation Sequencing Strategy.
- Author
-
Michelini S, Herbst KL, Precone V, Manara E, Marceddu G, Dautaj A, Maltese PE, Paolacci S, Ceccarini MR, Beccari T, Sorrentino E, Aquilanti B, Velluti V, Matera G, Gagliardi L, Miggiano GAD, and Bertelli M
- Abstract
Lipedema is a disabling disease characterized by symmetric enlargement of the lower and/or upper limbs due to deposits of subcutaneous fat, that is easily misdiagnosed. Lipedema can be primary or syndromic, and can be the main feature of phenotypically overlapping disorders. The aim of this study was to design a next-generation sequencing (NGS) panel to help in the diagnosis of lipedema by identifying genes specific for lipedema but also genes for overlapping diseases, and targets for tailored treatments. We developed an NGS gene panel consisting of 305 genes potentially associated with lipedema and putative overlapping diseases relevant to lipedema. The genomes of 162 Italian and American patients with lipedema were sequenced. Twenty-one deleterious variants, according to 3 out of 5 predictors, were detected in PLIN1 , LIPE , ALDH18A1 , PPARG , GHR , INSR , RYR1 , NPC1 , POMC , NR0B2 , GCKR , PPARA in 17 patients. This extended NGS-based approach has identified a number of gene variants that may be important in the diagnosis of lipedema, that may affect the phenotypic presentation of lipedema or that may cause disorders that could be confused with lipedema. This tool may be important for the diagnosis and treatment of people with pathologic subcutaneous fat tissue accumulation.
- Published
- 2022
- Full Text
- View/download PDF
49. A novel complex genomic rearrangement affecting the KCNJ2 regulatory region causes a variant of Cooks syndrome.
- Author
-
Cinque L, Micale L, Manara E, Esposito A, Palumbo O, Chiariello AM, Bianco S, Guerri G, Bertelli M, Giuffrida MG, Bernardini L, Notarangelo A, Nicodemi M, and Castori M
- Subjects
- Adolescent, Adult, Chromosome Breakpoints, Chromosomes, Human, Pair 1 genetics, Chromosomes, Human, Pair 17 genetics, Facies, Female, Humans, In Situ Hybridization, Fluorescence, Male, Potassium Channels, Inwardly Rectifying chemistry, Sequence Deletion, Translocation, Genetic, Young Adult, Fingers abnormalities, Foot Deformities, Congenital genetics, Gene Rearrangement, Hand Deformities, Congenital genetics, Potassium Channels, Inwardly Rectifying genetics, Regulatory Sequences, Nucleic Acid
- Abstract
Cooks syndrome (CS) is an ultrarare limb malformation due to in tandem microduplications involving KCNJ2 and extending to the 5' regulatory element of SOX9. To date, six CS families were resolved at the molecular level. Subsequent studies explored the evolutionary and pathological complexities of the SOX9-KCNJ2/Sox9-Kcnj2 locus, and suggested a key role for the formation of novel topologically associating domain (TAD) by inter-TAD duplications in causing CS. Here, we report a unique case of CS associated with a de novo 1;17 translocation affecting the KCNJ2 locus. On chromosome 17, the breakpoint mapped between KCNJ16 and KCNJ2, and combined with a ~ 5 kb deletion in the 5' of KCNJ2. Based on available capture Hi-C data, the breakpoint on chromosome 17 separated KCNJ2 from a putative enhancer. Gene expression analysis demonstrated downregulation of KCNJ2 in both patient's blood cells and cultured skin fibroblasts. Our findings suggest that a complex rearrangement falling in the 5' of KCNJ2 may mimic the developmental consequences of in tandem duplications affecting the SOX9-KCNJ2/Sox9-Kcnj2 locus. This finding adds weight to the notion of an intricate role of gene regulatory regions and, presumably, the related three-dimensional chromatin structure in normal and abnormal human morphology., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
50. Study of the effects of Lemna minor extracts on human immune cell populations.
- Author
-
Catelani Cardoso C, Miraldi E, Ceccarini MR, Naureen Z, Baini G, Manara E, Anpilogov K, Camilleri G, Dhuli K, Paolacci S, Ria F, Di Sante G, Camponeschi C, Tredicine M, Zanlari A, Chiurazzi P, Beccari T, and Bertelli M
- Subjects
- Cells, Cultured, Humans, Phytochemicals genetics, Phytochemicals isolation & purification, Phytochemicals pharmacology, Plant Extracts genetics, Plant Extracts isolation & purification, Araceae genetics, Immunomodulation drug effects, Immunomodulation immunology, Leukocytes, Mononuclear drug effects, Leukocytes, Mononuclear immunology, Plant Extracts pharmacology
- Abstract
Objective: Lemna minor is a plant with a huge repertoire of secondary metabolites. The literature indicates that extracts of Lemna minor have antioxidant, antiradical, immunomodulatory and anti-inflammatory properties. The objective of the present study was to find a suitable technique to extract active compounds from this plant and verify whether these extracts have immunomodulatory activity., Materials and Methods: We grew L. minor on a standard medium with Gamborg B5 and vitamins. We extracted compounds from the plant by maceration and decoction. The phytochemical profile of the extracts was characterized by chromatography, spectrophotometry, and spectroscopy. The extracts were tested on cultures of mononuclear cells from four human subjects. These cells were pulsed with carboxyfluorescein succinimidyl ester, grown in triplicate in standard culture medium without (control) and with increasing concentrations of Lemna extracts. Flow cytometry was used to evaluate cell death and proliferation of the total mononuclear cell population and of CD4+, CD8+, B cell and monocyte populations., Results: The Lemna extracts were not cytotoxic and did not cause cell necrosis or apoptosis in immune cells. At low concentrations, they induced very limited proliferation of CD4+ cells within 48 hours. At high concentrations, they induced proliferation of CD8+ cells and B lymphocytes within 48 hours., Conclusions: Unfortunately, we failed to confirm any immunomodulatory activity of Lemna extracts. Growth and death rates of human immune cells were not significantly affected by adding Lemna extracts to the culture medium.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.